| 摘要 |
FIELD: chemistry.SUBSTANCE: invention relates to arylpiperazine derivative of formulaits pharmaceutically acceptable salts, as well as to its deuterated form, possessing affinity with respect to D2, 5-HT1A and 5-HT2A receptors.EFFECT: compound can be used for treatment of schizophrenia and related psychotic disorders, such as acute maniacal disorder, bipolar disorder, autistic disorder and depression.7 cl, 14 ex |
